A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 59
[Display Entries]
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : OHE
Long Form : overt hepatic encephalopathy
No. Year Title Co-occurring Abbreviation
2020 Beneficial effects of L-ornithine L-aspartate for prevention of overt hepatic encephalopathy in patients with cirrhosis: a systematic review with meta-analysis. LOLA, RCTs
2020 Total area of spontaneous portosystemic shunts independently predicts hepatic encephalopathy and mortality in liver cirrhosis. SPSS, TSA
2019 Aberrant topological organization of the functional brain network associated with prior overt hepatic encephalopathy in cirrhotic patients. HC, PHES
2019 Development and Validation of a Prognostic Score to Predict Covert Hepatic Encephalopathy in Patients With Cirrhosis. CHE
2019 Diagnosis of covert hepatic encephalopathy: a multi-center study testing the utility of single versus combined testing. AUROC, CHE, ICT, PHES, StE
2019 Early-Recurrent Overt Hepatic Encephalopathy Is Associated with Reduced Survival in Cirrhotic Patients after Transjugular Intrahepatic Portosystemic Shunt Creation. CI, HR, MELD, TIPS
2019 Impaired cognition predicts the risk of hospitalization and death in cirrhosis. NIHTB, WHG
2019 Lactulose improves cognition, quality of life, and gut microbiota in minimal hepatic encephalopathy: A multicenter, randomized controlled trial. ChiCTR, MHE
2019 Prediction of overt hepatic encephalopathy by the continuous reaction time method and the portosystemic encephalopathy syndrome test in clinically mentally unimpaired patients with cirrhosis. CRT, PSE
10  2019 The influence of HE history, HE status and neuropsychological test type on learning ability in patients with cirrhosis. MELD, TMT-A
11  2019 [Analysis of influencing factors on hepatic encephalopathy in patients with non-cirrhotic portal hypertension]. HE, MHE, NCPH
12  2018 A Randomized Controlled Trial Comparing the Efficacy of a Combination of Rifaximin and Lactulose with Lactulose only in the Treatment of Overt Hepatic Encephalopathy. HE
13  2018 Association between non-variceal spontaneous portosystemic shunt and outcomes after TIPS in cirrhosis. SPSSs, TIPS
14  2018 Coil-Assisted Retrograde Transvenous Obliteration (CARTO): An Alternative Treatment Option for Refractory Hepatic Encephalopathy. CARTO, SPSSs
15  2018 Covered TIPS versus endoscopic band ligation plus propranolol for the prevention of variceal rebleeding in cirrhotic patients with portal vein thrombosis: a randomised controlled trial. EBL, PVT, TIPS
16  2018 Critical flicker frequency test predicts overt hepatic encephalopathy and survival in patients with liver cirrhosis. CFF, MHE
17  2018 Disrupted Brain Intrinsic Networks and Executive Dysfunction in Cirrhotic Patients without Overt Hepatic Encephalopathy. ECN, FC, PCC, SN
18  2018 Disrupted topological organization of brain structural network associated with prior overt hepatic encephalopathy in cirrhotic patients. HC, PHES
19  2018 Evaluation of the cost-effectiveness of rifaximin-alpha for the management of patients with hepatic encephalopathy in the United Kingdom. HE, ICER, NHS, QALYs, RCT, UK
20  2018 Impact of hepatic encephalopathy on liver transplant waiting list mortality in regions with different transplantation rates. HCC
21  2018 JianPi HuaZhuo XingNao formula (Chinese herbal medicine) for the treatment of minimal hepatic encephalopathy: a protocol for a randomized, placebo-controlled pilot trial. JPHZXN, MHE
22  2018 L-Carnitine for the Treatment of Overt Hepatic Encephalopathy in Patients with Advanced Liver Cirrhosis. BCAA, GCS, RFS
23  2018 L-ornithine L-aspartate in bouts of overt hepatic encephalopathy. LOLA
24  2018 Neuroprotective Effect of Nortriptyline in Overt Hepatic Encephalopathy Through Attenuation of Mitochondrial Dysfunction. BDL, cyt c, DAergic, mPTP, NT
25  2018 [Guidelines on the management of hepatic encephalopathy in cirrhosis]. HE, MHE
26  2017 Effect of physical exercise on sarcopaenia in patients with overt hepatic encephalopathy: a study protocol for a randomised controlled trial. PE
27  2017 Overt hepatic encephalopathy impairs learning on the EncephalApp stroop which is reversible after liver transplantation. ---
28  2017 The Effects of Probiotics and Symbiotics on Risk Factors for Hepatic Encephalopathy: A Systematic Review. CI, HE, MHE
29  2016 Diagnosis of Minimal Hepatic Encephalopathy Using Stroop EncephalApp: A Multicenter US-Based, Norm-Based Study. AR, ICT, MELD, MHE, PHES, VA
30  2016 Frontal assessment battery: A tool for screening minimal hepatic encephalopathy? FAB
31  2016 Overt hepatic encephalopathy: development of a novel clinician reported outcome tool and electronic caregiver diary. CG, WH
32  2016 Prospective Multicenter Observational Study of Overt Hepatic Encephalopathy. ---
33  2016 Screening for minimal hepatic encephalopathy in patients with cirrhosis by cirrhosis-related symptoms and a history of overt hepatic encephalopathy. CSS, MHE, PSQI
34  2015 Anomalous gray matter structural networks in patients with hepatitis B virus-related cirrhosis without overt hepatic encephalopathy. HBV-RC
35  2015 Cortical signature of patients with HBV-related cirrhosis without overt hepatic encephalopathy: a morphometric analysis. fMRI, HBV-RC, LGI, PHES
36  2015 Covert and Overt Hepatic Encephalopathy: Diagnosis and Management. CHE, HE
37  2015 Legal Responsibilities of Physicians When They Diagnose Hepatic Encephalopathy. CHE
38  2015 Prospective comparative study of inhibitory control test and psychometric hepatic encephalopathy score for diagnosis and prognosis of minimal hepatic encephalopathy in cirrhotic patients in the Indian subcontinent. CI, ICT, MHE, PHES
39  2015 Resting State-fMRI with ReHo Analysis as a Non-Invasive Modality for the Prognosis of Cirrhotic Patients with Overt Hepatic Encephalopathy. ReHo, rs-fMRI
40  2015 Systematic review with network meta-analysis: the comparative effectiveness and safety of interventions in patients with overt hepatic encephalopathy. BCAA, MD, ORs
41  2014 Brain regional homogeneity changes following transjugular intrahepatic portosystemic shunt in cirrhotic patients support cerebral adaptability theory--a resting-state functional MRI study. ACC, DST, fMRI, KCC, M/STG, MFG, NCT-A, PCC, ReHo, SMA, SPG, TIPS
42  2014 Cognitive impairment and electroencephalographic alterations before and after liver transplantation: what is reversible? EEG, LT
43  2014 Hepatic encephalopathy: how to test and treat. CHE
44  2014 Oral l-ornithine-l-aspartate in minimal hepatic encephalopathy: A randomized, double-blind, placebo-controlled trial. CFF, CP, DSST, LD-QOL, LOLA, MHE, qEEG
45  2014 Pre-transjugular intrahepatic portosystemic shunts (TIPS) prediction of post-TIPS overt hepatic encephalopathy: the critical flicker frequency is more accurate than psychometric tests. CFF, MHE, PHES, TIPS
46  2013 Abnormal baseline brain activity in patients with HBV-related cirrhosis without overt hepatic encephalopathy revealed by resting-state functional MRI. ALFF, HBV-RC, PHES
47  2013 Abnormal regional homogeneity of resting-state brain activity in patients with HBV-related cirrhosis without overt hepatic encephalopathy. HBV-RC, PHES, ReHo, rs-fMRI
48  2013 Correlation between interleukin-6 and ammonia in patients with overt hepatic encephalopathy due to cirrhosis. IL-6
49  2012 Changes in cerebral blood flow after transjugular intrahepatic portosystemic shunt can help predict the development of hepatic encephalopathy: an arterial spin labeling MR study. ASL, CBF, TIPS
50  2012 Diagnosis and treatment of minimal hepatic encephalopathy to prevent motor vehicle accidents: a cost-effectiveness analysis. ICT, MHE, MVAs, NPE, SPTs
51  2011 Diet and cognition in chronic liver disease. MHE
52  2011 Evidence of persistent cognitive impairment after resolution of overt hepatic encephalopathy. PHES
53  2011 Validation of the psychometric hepatic encephalopathy score (PHES) for identifying patients with minimal hepatic encephalopathy. MHE, PHES, PHES
54  2009 Impairment of driving ability and neuropsychological function in patients with MHE disease. MHE
55  2009 Long-term evaluation of cognitive function and cerebral metabolism in liver transplanted patients. PET
56  2008 Inhibitory control test for the diagnosis of minimal hepatic encephalopathy. ICT, MA, MHE, SPT, TIPS
57  2008 Probiotic yogurt for the treatment of minimal hepatic encephalopathy. BDT, DST, IL, MELD, MHE, NCT-A, SF, TNF
58  2007 Inhibitory control test is a simple method to diagnose minimal hepatic encephalopathy and predict development of overt hepatic encephalopathy. ICT, MHE, SPT
59  2001 Prevalence and prognostic value of quantified electroencephalogram (EEG) alterations in cirrhotic patients. CI, EEG, HR, OR